Related by context. All words. (Click for frequent words.) 73 Cross Licensing Agreement 73 Patent License Agreement 70 License Pact 67 Acacia Subsidiary 67 Files Provisional 66 Patent Infringement Litigation 66 Worldwide Licensing Agreement 66 Announce Collaboration Agreement 66 Licensing Pact 66 Begins Shipment 66 Patent Licensing Agreement 65 Issued Patent 65 Exclusive Licensing Agreement 65 Exclusive License 64 Settles Patent Litigation 64 Wins Patent Infringement 64 License Option Agreement 64 Patent Lawsuit Against 64 Patent Lawsuit 64 Announce License Agreement 63 Sublicense Agreement 63 Settle Patent Litigation 63 Patent Infringement Suit 63 Exclusive License Agreement 63 Files Patent Infringement 63 Patent Dispute 62 Patent Infringement Lawsuit Against 62 Patents Issued 62 Secures Patent 62 Value Added Reseller Agreement 62 Extends Collaboration 62 Patent Infringement Case 62 Licensing Deal 62 Permanent Injunction Against 62 Receives Favorable Ruling 62 Acquire Privately Held 62 Taro Receives 61 Inks License 61 Announce Licensing 61 Announces Licensing Agreement 61 Settle Litigation 61 Definitive Merger Agreement 61 Expand Collaboration 61 Milestone Payment 61 Licensing Agreements 61 Obtains Exclusive License 61 Sign License Agreement 61 Inks Licensing Deal 61 Signs License Agreement 61 Taglich Brothers Initiates Coverage 61 Files Patent Application 61 Patent Portfolio 61 Distributorship Agreement 60 Commercialization Agreement 60 Patent Infringement Action 60 Biomarker Study 60 Infringement Case 60 Announces FDA Clearance 60 Patents Upheld 60 Awarded Patents 60 Patent Infringement Lawsuit 60 Achieves Milestone 60 Settles Patent Infringement Lawsuit 60 Enters Into Exclusive 60 Receives CE Marking 60 Reseller Agreement 60 Enters Into Licensing Agreement 60 Patent Issued 60 Announces License Agreement 60 Distribution Agreements 60 Global Reseller Agreement 60 Settle Patent Dispute 60 No. RE# [001] 60 Distribution Pact 59 Patent Reexamination 59 Key Milestones 59 Restructures Operations 59 Patent Infringement Suit Against 59 Enters Into License Agreement 59 Diomed Holdings 59 Exclusive Licensing 59 Collaboration Agreement 59 Extend Collaboration 59 Expands Portfolio 59 BIOLASE Announces 59 Non Infringement 59 Develop Novel 59 Develop Next Generation 59 Trademark Infringement Lawsuit 59 Obtains License 59 Subsidiary Enters 59 Acacia Subsidiary Enters 59 Licensing Agreement 59 Restructures Debt 59 Immunomedics Announces 59 Nasdaq Delisting Notice 59 Nanophase Announces 59 Patent Litigation 59 Receives Milestone Payment 59 Develop Innovative 58 Files IND 58 Teaming Agreement 58 Gets FDA Clearance 58 MOTOROLA Motorola 58 Signs Merger Agreement 58 Announce Interoperability 58 Modem Card 58 Signs Licensing Agreement 58 Patent Infringement 58 Board Authorizes 58 Polysilicon Supply Agreement 58 Reseller Relationship 58 Intellectual Property Portfolio 58 Patent Suit Against 58 Accelerate Commercialization 58 Settles Litigation 58 Exclusive Distribution 58 Prometheus Laboratories 58 Extend Partnership 58 Files Patent Infringement Lawsuit 58 Enters Into Distribution 58 Receives Patent 58 Strengthens Position 58 Sign Licensing Agreement 58 Supply Agreements 58 EMD Biosciences Inc. 58 Submits Application 58 Settles Patent 58 Initiates Patent Infringement 58 ULDAGE 58 Milestone Payments 58 Legal Dispute 58 Completes Reverse Merger 58 Licenses Patents 58 For Undisclosed Terms 58 Announce Licensing Agreement 58 Terminates Merger Agreement 58 Announces Definitive Agreement 58 Favorable Ruling 58 Distributor Agreement 58 Amends Agreement 58 Settles Patent Dispute 58 Corporation SiGen 58 Settle Patent 58 Receives Funding 57 NASDAQ Listing Requirements 57 Commercializes 57 Announces Favorable Ruling 57 Exclusive Licensee 57 ProChon Biotech 57 Photovoltaic Module 57 Nasdaq Delisting 57 Strengthens Balance Sheet 57 resolves patent infringement 57 Regulatory Clearance 57 Syntonix Pharmaceuticals 57 Acacia Subsidiary Acquires 57 Inks Distribution 57 Inks Supply 57 License Agreement 57 Announce Merger Agreement 57 Cavitation Technologies 57 Sublicense 57 Multimillion Dollar Contract 57 Obtains Exclusive Rights 57 oligonucleotides Manoharan 57 Biotech Firm 57 Pending Litigation 57 Expands Scope 57 Ventures Invests 57 Enters Into Collaboration 57 Patent Upheld 57 Therapeutic Competitors Report 57 GLGL 57 FDA Clears 57 Enters Into Settlement Agreement 57 Proxy Proposals 57 Nova Measuring 57 Ryogen 57 Sign Definitive Merger 57 Successfully Completes Tender Offer 57 Achieves ISO #:# Certification [002] 57 Insulin Pen 57 Flagship Product 57 Arbitration Proceeding 57 Patent Suit 57 Files Patent Infringement Suit 57 Influenza Vaccine Production 57 BioSyent Pharma 57 Extends Capabilities 57 Derivative Lawsuit 57 Microwave Ablation System 57 Antibody Discovery 56 Patent Invalid 56 Settles Patent Suit 56 Initiates Clinical 56 Reexamination Certificate 56 Dramatically Expands 56 Confirms Commitment 56 Receives Clearance 56 hi fn inc 56 Initiates Clinical Trials 56 Completes Tender Offer 56 TM MMP Portfolio 56 Expanded Indication 56 Announces Immediate Availability 56 InNexus Biotechnology 56 Acquire Controlling Interest 56 Distribution Agreement 56 OTC MNDP 56 Awarded Multi 56 Receives Confirmation 56 Affiliation Agreement 56 Optical Sensors 56 Announces Stockholder Approval 56 Pending Acquisition 56 Diamyd Medical Diamyd 56 Patent Infringement Claims 56 Closes Merger 56 Reach Settlement Agreement 56 Introduces Breakthrough 56 Awarded GSA Schedule 56 Submits NDA 56 Shimadzu Corporation 56 Collaborates With 56 Initiates Phase II 56 Milestone Payment From 56 Earns Milestone Payment 56 Announce Settlement 56 Buy Privately Held 56 Reports Inducement Grants 56 Alnylam Nasdaq ALNY 56 Teva Provides Update 56 Patented Technology 56 Regains Nasdaq 56 Broadens Scope 56 Ucyclyd Pharma Inc. 56 Delivers Next Generation 56 Pieris AG 56 Files Patents 56 Enters Into Joint Venture 56 Purchases Moore Microprocessor 56 Announce Early Termination 56 Acquire Assets 56 Patent Infringement Lawsuits 56 Wins Summary Judgment 56 Million Dollar Contract 56 Terminate Agreement 56 Cardioxyl Pharmaceuticals 56 Trademark Lawsuit 56 Flamel Technologies Announces 56 Streamlines Operations 56 Metamaterial 56 Registration Statement Declared Effective 56 Amend Merger Agreement 56 Reseller Partnership 56 Handok Pharmaceuticals 56 Initiates Enrollment 56 BioSante Pharmaceuticals Announces 56 Receive Milestone Payment 56 Enters Into Definitive 56 Patent Covering 56 Misonix Announces 56 Common Share Repurchase Program 56 Files Patent 56 Restate Financials 56 Patent Filing 56 Nanolithography 56 Signs Licensing 56 Patent Suits 55 Introduces Revolutionary 55 TRANSDUR ™ 55 Announcement acc 55 FDA Approvals 55 Preliminary Injunction Against 55 Inc. LATEST NEWS 55 Named Exclusive Distributor 55 Interdigital 55 CoCreate Software GmbH 55 ASX BLT 55 Terminate Merger Agreement 55 HSR Waiting Period 55 Mersana Therapeutics Inc. 55 Sensor Interface 55 Sign Definitive Agreement 55 Develops Novel 55 Unveils Groundbreaking 55 Achieves Milestones 55 exclusive licensor 55 Strengthens Relationship 55 HuCAL PLATINUM R 55 Receives FDA Clearance 55 Initiates Clinical Trial 55 HARDI Electronics 55 #.#.# Meldung [001] 55 Announces Spin Off 55 Integra Lifesciences 55 Collaborators Publish 55 #,#,# B2 55 VIASPACE Subsidiary 55 Complete Merger 55 License Agreements 55 Durect Corporation 55 Systemic Delivery 55 Unsolicited Proposal From 55 Supplemental Biologics License Application 55 Completes Enrollment 55 Takeda Pharma 55 Terminate Merger 55 DARA logo 55 Receives Authorization 55 Arch Biopartners 55 Mutually Agree 55 Announces Reverse Merger 55 Successfully Demonstrates 55 Files Shelf Registration Statement 55 Enters Joint Venture 55 VCRT 55 ASSET ScanWorks 55 Vigorously Defend 55 Receives NASDAQ 55 Expands Capabilities 55 Alligator Bioscience AB 55 Lung Cancer Drug 55 Reduces Debt 55 Seasonal Influenza Vaccine 55 Q1 Profit Decreases 55 www.nano 55 Ichor Medical Systems 55 Receives Orphan Drug Designation 55 Zor Pharmaceuticals 55 Settles Dispute 55 Biomerix 55 Entered Into 55 Nasdaq Delisting Notification 55 Magnetoresistive Random Access 55 Finalizes Joint Venture 55 Nasdaq Listing Requirements 55 Master License Agreement 55 Signs Distribution 55 Successfully Integrates 55 Emphasys Medical 55 HHSN#C 55 Announces Effective Date 55 Receives Favorable 55 FabricStream 55 Taisho Pharmaceuticals 55 Demonstrates Interoperability 55 Computational Lithography 55 Announces Definitive Agreements 55 Resolves Dispute 55 Expand Relationship 55 3D Interconnect 55 News Unternehmensnachrichten DGAP Adhoc 55 Subsidiary Enters Into 54 Markman Hearing 54 Material Transfer 54 patent EP# 54 BioElectronics Corporation Announces 54 Refinances Debt 54 Commercially Available 54 Patent Infringement Claim 54 Completes Patient Enrollment 54 OTC IPXL 54 Photovoltaic Cells 54 Compression Labs Inc. 54 Provides Update Regarding 54 Wafer Bonding 54 Introduces Enhanced 54 Achieves Significant 54 Begin Clinical Trials 54 Option Grants 54 Infringed 54 Anti CD# Antibody 54 Antitrust Settlement 54 DayTradersDigest.com Profiles 54 Reaches Settlement Agreement 54 Uses Thereof 54 Licenses Novel 54 Commences Subsequent 54 Completes Asset 54 GRAS Status 54 Stock Buyback Program 54 DIAGNOS Announces 54 HuCAL GOLD R 54 Receives ISO #:# [001] 54 Sign Reseller Agreement 54 Miraculins Announces 54 Psoriasis Drug 54 Completes Financing 54 Patents Covering 54 Vicor Technologies Announces 54 Completes Recapitalization 54 Announces Tentative Approval 54 Significant Milestones 54 Signs Non Binding 54 Exploring Strategic Alternatives 54 Receives SFDA Approval 54 Testosterone Gel 54 Starts Shipping 54 Unveils Revolutionary 54 Tri Brid Engine Electric/Flex-Fuels/H2O 54 PDUFA Date 54 Finalize Agreement 54 Receives Orphan Drug 54 Synerx 54 CancerVax Corporation 54 Linvatec 54 Announces Reverse Split 54 Share Issuance 54 Unveils Expanded 54 DuNE 54 Nihon Kohden Corporation 54 Asset Swap 54 Recombinant Protein 54 Molecular Profiling 54 Pending Merger 54 Illumination System 54 Subsidiary Expands 54 Patent Validity 54 Announces Proposed Settlement 54 Awarded Contract Extension 54 HLNAND 54 Galenea 54 Metrologic Instruments 54 Alseres Pharmaceuticals Inc. 54 Cytokine PharmaSciences 54 Becomes Effective 54 Funding Commitment 54 Unveils Breakthrough 54 Achieves Certification 54 Quark Biotech 54 Announces Dismissal 54 WARF stem cell 54 Regains NASDAQ 54 Wafer Supply 54 Jointly Offer 54 Infringement Suit 54 Retains CCG Investor Relations 54 Transdermal Drug 54 Secures Additional 54 MorphoSys proprietary 54 Reports Receipt 54 Explores Strategic Alternatives 54 BRUKER 54 Licence Agreement 54 Extends Tender Offer 54 Patent Ruling 54 Completes Reorganization 54 Paratek Pharmaceuticals Inc. 54 Inc. NYSE ARW 54 Enhances User Experience 54 Sanochemia Pharmazeutika AG 54 Completes Buyout 54 euro adhoc Intercell AG 54 Secures Financing 54 Significant Milestone 54 UMN Pharma 54 ZapMedia applied 54 Patent Infringements 54 Announce Expiration 54 Subsidiary Signs 54 Expands Internationally 54 Awarded Patent 54 Expedited Review 54 Provides Status 54 Spectros 54 Signs Definitive 54 Enters Exclusive 54 Achieves ISO # 54 Inks MOU 54 Fresenius Biotech 54 Patent Issuance 54 CybeRelease OTC 54 Unveils Newest 53 Galderma SA 53 Marks Milestone 53 InterfeRx 53 Extend Relationship 53 BXT # 53 Receives Initial 53 XEROX CORPORATION 53 Artificial Cornea 53 MedGenesis 53 Gene Expression Analysis 53 EDIG 53 Therapeutic Competitors Companies 53 Remain Listed 53 Gentamicin Surgical Implant 53 Withdraws Application 53 Subsidiary Awarded Contract 53 exclusive sublicense 53 No. #-# Fed. 53 Develops Innovative 53 Long Term Lease 53 Inovio Pharmaceuticals 53 Patent Disputes 53 CorePharma 53 Technol 53 Definitive Agreements 53 Gout Drug 53 Granted Orphan Drug 53 Gets Favorable 53 Memory MRAM 53 Inks Long Term 53 Patent Nos. 53 Strand Genomics 53 Mentor Protege Agreement 53 Zygogen 53 Patent Licensing 53 Receives Commitment 53 Announces Favorable 53 Announces Definitive Merger 53 Subsidiary Receives 53 visit http:/www.mannkindcorp.com 53 Submits IND 53 Introduces Next Generation 53 Manufacturer Selects 53 Prostate Cancer Vaccine 53 Commenced Against 53 LongRun2 technologies 53 Wins Approval 53 Closes Financing 53 Generic Versions 53 Organon Pharmaceuticals 53 FY# Loss Widens 53 SF Lease 53 Initiates Dosing 53 Announces Effectiveness 53 Drug Candidate 53 Receives Tentative Approval 53 NIMBUS ® 53 Completes Merger 53 Daiichi Suntory Pharma 53 Sunesis Pharma 53 Completes Merger With 53 EyeTel 53 NeutroPhase TM 53 AMEX RGN 53 Obtains Financing 53 Enters Into Long Term 53 Demonstrates Commitment 53 FORG 53 Envirokare Tech Inc. 53 METHOD FOR 53 WORLDWIDE INC. 53 Oncolys BioPharma 53 called Microstructure Chromatograph 53 Roche Diagnostics GmbH 53 Achieves ISO #:# Certification [001] 53 Seikagaku Corporation 53 FDA Okays 53 Lease Renewal 53 Creditor Protection 53 Diatos SA 53 Rapid Expansion 53 Successfully Concludes 53 SansRosa 53 Reduces Cost 53 Nanobody R 53 Surfect Holdings Inc. 53 Ercole Biotech 53 Stock Repurchase Plan 53 Diagnostica 53 ENSL 53 Long P.A. Announces 53 Stockholders Approve Merger 53 Unveils Enhancements 53 Has Entered Into 53 Vendum Batteries 53 China PharmaHub 53 Enters Definitive Agreement 53 Migraine Drug 53 NYSE Amex Listing 53 IPSEN 53 Terminates Agreement 53 Ascent Therapeutics 53 Lawsuit Involving 53 APLAC 53 Evaluate Strategic Alternatives 53 Rheumatoid Arthritis Drug 53 Earns Certification 53 Announces Issuance 53 QuantRx Biomedical Corporation 53 Study Validates 53 Unsolicited Tender Offer 53 Raven Biotechnologies 53 Pandel R 53 Q2 Loss Narrows 53 Jointly Announce 53 Taiho Pharmaceutical 53 Completes Transaction 53 Derma Sciences Announces 53 Convertible Debenture Financing 53 Enters Into LOI 53 Announces Debt Settlement 53 Boosts Productivity 53 Signs Purchase Agreement 53 Flexpoint Announces 53 Reaches Definitive Agreement 53 Middleware Solution 53 Broadens Its 53 Releases Upgraded 53 OTCBB PYTO 53 Merger Transaction 53 NanoTherapies 53 Financing Agreements 53 VentiRx Pharmaceuticals 53 Announces Early Termination 53 Expands Lineup 53 Saflink Corporation 53 Becomes Authorized 53 Enrolls First 53 Enters Agreement 53 purchased Moore Microprocessor 53 Dendritic Nanotechnologies Inc. 53 Vaccine Adjuvants 53 Impax Labs 53 Inks Multi 52 Intravascular 52 Antitrust Lawsuit Against 52 OFDM OFDMA 52 XEROX R 52 Alza Corporation 52 Trademark Dispute 52 Presents Positive Preclinical 52 BOCX 52 UCB Pharma SA 52 Microfluidic Device 52 Announce Collaboration 52 Expands Relationship With 52 Acquistion 52 Explore Strategic Alternatives 52 Uracyst R Test 52 Receives Notification 52 Hip Prosthesis 52 Integra LifeSciences Announces 52 AdvanSource Biomaterials Announces 52 Corp. IART 52 CysDisplay R 52 Strengthens Leadership 52 Bupropion HCl ER 52 Daytradersdigest.com 52 Completes Expansion 52 Strategic Relationship 52 Awarded GSA 52 Infringes 52 Debuts Next Generation 52 Articulation Agreement 52 Gets Clearance 52 Patent Filings 52 STERIS Corporation Announces 52 Transfer Agreement 52 AMEX BVX 52 Underscores Commitment 52 Biosearch 52 Enters Strategic 52 Bioresearch 52 Schizophrenia Drug 52 SFDA Approval 52 AMPLATZER R 52 Induced Pluripotent Stem Cells 52 Q3 Loss Widens 52 Introduces Powerful 52 Laser Diode 52 RAZADYNE R 52 Vistec Electron Beam 52 Shareholder Investigation 52 Vapor Deposition 52 Frankfurt XMPA 52 Receives Approvals 52 Antitrust Clearance 52 Nasdaq LGND 52 Jos. Schneider 52 iPS Academia Japan 52 Ceragenix 52 Q2 Loss Widens 52 Gets Favorable Ruling 52 USOTC SSWC 52 NASDAQ DRRX 52 Introduces Expanded 52 Initial Shipment 52 Forges Partnership 52 MSON 52 Liability Lawsuits 52 Provides Shareholder 52 Completes Restatement 52 Files Annual Report 52 Releases Enhanced 52 Confirms Filing 52 FDA Accepts 52 Wafer Manufacturing 52 Share Repurchase Plan 52 Clinical Trial Data 52 Consummates 52 Announces Initiation 52 Wavefront Coding 52 Shionogi Pharma 52 Newly Merged 52 Wholly owned Subsidiary 52 SPI Dynamics Incorporated 52 Jointly Develop 52 Protiva Biotherapeutics 52 Tibotec BVBA 52 Drug Coated Stent 52 Settles Lawsuits 52 Cellgate Inc. 52 CyDex Pharmaceuticals 52 Fast Track Status 52 Covalon Technologies 52 Announces Consummation 52 Merge Healthcare Announces 52 Antitrust Lawsuit 52 Summary Judgment Motions 52 Declaratory Judgment 52 DTC Eligibility 52 RotoView 52 CustomCall Data Systems 52 www.shamrockstocks.com About 52 SENSIO Technologies 52 BCD Semiconductor 52 Generic Protonix 52 Announces Cancellation 52 Presents Preclinical Data 52 PerkinElmer Acquires 52 Transcatheter Valve 52 Receives Stockholder Approval 52 Acquires Exclusive 52 Captisol ® 52 vivo fluorescence imaging 52 Announces Intent 52 M2M Modules 52 IBM Chartered Semiconductor 52 Tablet Device 52 Patent Spat 52 Acquisition Proposal 52 Successfully Tested 52 Enters Into Strategic 52 SAFLUTAN 52 Supply Agreement 52 Patent Nos. #,#,# #,#,# 52 Privately Held 52 Scanning Probe Microscope 52 Terminates Contract 52 Patent Infringement Complaint 52 Accelerates Expansion 52 Oncolys 52 Regains Full 52 XNOM 52 Permanent Injunction 52 Receives Certification 52 Announces Termination 52 Biosign Technologies Inc. 52 Balance Sheet Restructuring 52 Planned Acquisition 52 Binding Agreement 52 SpeBio joint venture 52 Obtains Approval 52 Identifies Potential 52 Arthritis Drug 52 Inks Pact 52 Shareholders Approve Merger Agreement 52 LDK Solar Signs 52 Mixed Signal IC 52 Regains Compliance 52 Through Glycoscience ® 52 Obtains Patent 52 BSKB 52 AMPLATZER ® 52 Teikoku Seiyaku 52 Provide Comprehensive 52 V3D 52 Receives Fast Track 52 OTCBB CVDT 52 Odyssey Thera 52 Consolidates Operations 52 Approves Share Repurchase 52 Small Molecule 52 Announce Expanded 52 Q1 Loss Widens 52 Not Disclosed 52 ELADUR TM 52 DNA Microarray 52 Loramyc ™ 52 Secures Contract 52 Signs Agreements 52 Clinical Trial Results 52 Merz Pharma GmbH 52 Software Simplifies 52 Caleco Pharma 52 Hollow Fiber 52 Major Step Toward 52 DataTern 52 Finalizes Acquisition 52 Announce Joint Venture 52 Teikoku Pharma USA 52 Receives Shareholder Approval 52 Achieves Prestigious 52 Joint Venture Agreements 52 Voluntarily Withdraw 52 Workflow Solution 52 # D# 52 Granted Early Termination 52 Completes Purchase Of 52 Double Patterning 52 EB Elektrobit 52 Contracts Totaling 52 Inc. PinkSheets 52 Achieves Record Sales 52 Authorized Generic 52 AB OMXS BINV 52 Subsidiary Awarded 52 Microfluidic Systems 52 Issues Clarification 52 REC ASA 52 Orapred ODT 52 Unions Reach Tentative 52 Avian Flu Vaccine 52 Q3 Loss Narrows 52 Synthetic Peptide 51 RxKinetix 51 Kyto Biopharma Inc. 51 Forges Strategic 51 Begins Shipping 51 b#x# http:/#.#.#.#/fls.geo/PH #x# #.hyahrtzeit 51 NASDAQ SURG 51 Mask Aligner 51 Nano Scale 51 Confidentiality Agreement 51 Therapeutic Antibody 51 Dismiss Lawsuit 51 Completes Transition 51 Finalize Joint Venture 51 Strengthens Commitment 51 Submits Supplemental 51 HealthSonix Inc. 51 NASDAQ Delisting 51 Enters Into Partnership 51 Submits Revised 51 A5 Laboratories Inc. 51 Launches Redesigned Website 51 NASDAQ CALP 51 Executes Letter 51 Conditional Approval 51 Signs Reseller Agreement 51 Tablet Formulation 51 Power3 Medical 51 Regains Compliance With 51 Earns Certified Partner 51 Files Amended 51 Establish Strategic 51 Successfully Defends 51 Aradigm Logo 51 Molecular Diagnostic 51 Engages CHF Investor Relations 51 Norgine BV 51 Generic Version Of 51 Concludes Successful 51 Obtains Exclusive 51 AudioFAX 51 Receives ISO #:# [002] 51 ASNAP 51 Assigned Patent 51 Primus Pharmaceuticals 51 Seeks Approval 51 Xennex 51 Submits Bid 51 Formalizes 51 GTC NASDAQ GTCB 51 Ortho Cept 51 quicComm 51 Becomes Wholly Owned Subsidiary 51 Declares Dividend Quick Facts 51 Expands Availability 51 Nycomed GmbH 51 Clears Path 51 Milestone Achieved 51 LightLab Imaging 51 Demonstrate Next Generation 51 Malpractice Suit 51 Jiangbo Pharmaceuticals 51 Hyperion Catalysis International 51 Significantly Enhances 51 Enter Into Definitive 51 sci worx 51 BioGlue ® 51 Inks Licensing Agreement 51 Court Invalidates 51 Completes Installation 51 Collagen Matrix 51 BioGenex 51 VIOXX Product 51 KINAXO 51 Settles Charges 51 Announces Reseller Agreement 51 NYSE MRX 51 Mylan Receives Approval 51 Electron Beam Lithography 51 MBMI Closes 51 Stratos Renewables 51 Q1 Loss Narrows 51 Extends Relationship 51 POTELLIGENT R Technology 51 OTCBB SUFH 51 Wound Dressing 51 Antitrust Suit 51 Medisorb ® 51 Acticon 51 OTC MARKETS 51 Momentum Grows 51 Settlement Agreement Regarding 51 DispersinB R 51 Secures Funding 51 Fraud Suit 51 :/ finance.yahoo.com q 51 Countersuit 51 ImaginAb 51 MMP Portfolio license 51 Adopts Stockholder Rights 51 Generic Version 51 Interconnection Agreement 51 Expands Globally 51 Enters Negotiations 51 Enhanced Capabilities 51 POTELLIGENT R 51 Spins Off 51 Asthma Inhaler 51 BRILINTA 51 Advancis Pharmaceutical Corporation 51 BridgeLux 51 Proves Successful 51 Nanofiber 51 Locked Nucleic Acid 51 Approve Merger 51 Important Milestone 51 Stimmrechte 51 Confirms Validity 51 Fuel Cell Stack 51 GMP Certificate 51 Bioheart Inc. 51 Inks Exclusive 51 OTCBB PYTO FWB ET6 51 LecTec Corporation 51 Confirms Efficacy 51 Further Validates 51 Nasdaq ACTG announced 51 Buys Majority Stake 51 Wider Networks 51 Receives FDA Approvable 51 Shelf Registration Statement 51 Announces Rebranding 51 k Premarket Notification 51 RainStorm 51 FDA Approves Generic 51 Nasdaq ALNY 51 Cenomed 51 Cavit Sciences Inc. 51 Announces Organizational Changes 51 Implantable Medical 51 Successfully Completed 51 IFUE 51 CorePharma LLC 51 Deliver Innovative 51 Commercialize 51 Attorneys Fees 51 Apricus Biosciences Inc. 51 commercializing Loramyc ® 51 SymbolPLUS 51 OPTi 51 Partners Invests 51 Rubicor Medical 51 Receives Notice From 51 Impax Laboratories Confirms 51 Conforce International 51 Cerner logo 51 Meso Scale Diagnostics 51 TapImmune Inc. 51 Announces Recapitalization 51 Accelerates Growth 51 MorphoSys AG FSE MOR 51 Subsidiary Wins 51 SRL Biovail 51 O2Micro Granted 51 GS FLX TITANIUM 51 Inc. AMEX CTT 51 Oligonucleotide 51 Aldara ® 51 Cerner Cerner Cerner Millennium 51 Outlines Strategy 51 Signs Binding 51 MONSTERSTOX.COM Monsterstox.com 51 Biolitec 51 Advanced Biotechnologies 51 Surfect Technologies 51 MobileMedia 51 Inc. PINKSHEETS RELM 51 Signs Option Agreement 51 RGIN 51 X Ceptor